Alert: Granuflo Has Been Link to Serious Health Issues, Including Heart Attack, Stroke and Cardiopulmonary Arrest

DALLAS –(May 2, 2013) –Baron and Budd, a nationally recognized plaintiffs’ law firm, is now handling lawsuits related to the Granuflo recall. Granuflo is the brand name of a dialysate used in dialysis, a long-term medical treatment used to treat kidney conditions, and has been linked to various health issues, such as heart attack and stroke. Baron and Budd Granuflo lawyers are currently working to assist patients and families that have suffered significant health issues after using Granuflo.

On March 29, 2012, the Federal Drug Administration (FDA) issued a Granuflo recall to revise the drug’s prescribing instructions. The recall stated that using Granuflo could lead to significant heart problems in patients, such as cardiac arrhythmia and low blood pressure.  However, the manufacturer of Granuflo, Fresenius, knew that the product could harm patients before it was even released onto the market, according to an internal company memo.

“Just because your doctor prescribes something does not always mean that it is safe, and not because the doctor is wrong, but because the manufacturer has actively chosen to hide the truth about their product,” said Russell Budd, president and managing shareholder at Baron and Budd. “Granuflo is a perfect example of how corporate negligence can harm people. If Fresenius chose to conduct more tests on Granuflo to make certain that it was safe prior to release, we may not be having these issues now.”

Fresenius Medical Care is the world’s largest producer of products and services for kidney dialysis and more than one-third of the over 400,000 Americans who undergo dialysis treatments each year go to Fresenius clinics.

If you or someone you know has received Granuflo treatments and suffered serious health issues, contact our Granuflo lawyers today at 1.866.844.4556 or email us at info@baronbudd.com. For more information about Granuflo lawyers and Baron and Budd, visit Baron and Budd’s website here: //baronandbudd.com/areas-of-practice/pharmaceuticals/granuflo-lawyer/.

For more than 35 years, Baron and Budd lawyers have been protecting the rights of people against negligent companies. The firm has an established track record of success when going up against large corporations, including pharmaceutical companies. Recently, our lawyers were involved in the litigation surrounding diabetes drug Avandia. Baron and Budd represented more than 7,000 patients harmed by Avandia use, and currently represents numerous states in lawsuits against manufacturer GlaxoSmithKline. In the 1990s, the firm was closely involved in the litigation surrounding then-popular diet drug Fen-Phen. The resulting settlement was valued at over $1.275 billion.

About Baron & Budd

The law firm of Baron & Budd, with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with over 35 years of “Protecting What’s Right” for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and medical devices, Chinese drywall, deceptive advertising, consumer financial fraud, securities fraud and asbestos cancers such as mesothelioma.